Review Article|Articles in Press

Pre and postoperative diarrhoea associated with neuroblastoma resection – A systematic review of published studies


      Neuroblastoma is a malignant tumour affecting 10.5/1 million children annually. It arises from sympathetic nervous system precursor cells and is most frequently found in the adrenal gland and abdominal paravertebral ganglia. Diarrhoea as a presenting symptom of neuroblastoma is uncommon and usually linked to vasoactive intestinal peptide (VIP) tumour secretion. Even more rarely, postoperative diarrhoea may follow neuroblastoma tumour resection. Published studies generally associate postoperative diarrhoea with subadventitial tumour resection. These findings are however based on a handful of reports. This systematic review therefore aims to analyse the true incidence of postoperative diarrhoea and its morbid correlation with the extent/type of surgical resection. Pubmed/Embase databases were searched according to PRISMA guidelines. Final analysis consisted of 16 studies: N = 779 patients. Postoperative diarrhoea was significantly more common in all patients who underwent subadventitial resection compared to non subadventitial resection, p < 0.001 (OR 25.9, 95% CI 9.3–72.4). 5-year survival rates were equivalent in both groups. Preoperative diarrhoea was rarely reported in studies and always strongly linked to elevated VIP secretion. In the majority of neuroblastoma patients, preoperative diarrhoea ameliorated after gross tumour resection with elevated VIP normalized. The operative technique of subadventitial neuroblastoma resection portends significant risk(s) of post operative diarrhoea not seen in those patients undergoing other classical methods of tumour resection with 5-year survival rates strikingly similar. These findings affirm that subadventitial tumour resection should be avoided when undertaking surgery for neuroblastoma to minimize the risk(s) of persistent postoperative diarrhoea.



      VIP (vasoactive intestinal peptide)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Park J.R.
        • Eggert A.
        • Caron H.
        Neuroblastoma: biology, prognosis, and treatment.
        Hematol Oncol Clin N Am. 2010; 24: 65-86
        • Tsubota S.
        • Kadomatsu K.
        Origin and initiation mechanisms of neuroblastoma.
        Cell Tissue Res. 2018; 372: 211-221
        • Brodeur G.M.
        • Pritchard J.
        • Berthold F.
        • Carlsen N.L.
        • Castel V.
        • Castelberry R.P.
        • et al.
        Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
        J Clin Oncol. 1993; 11: 1466-1477
        • Cohn S.L.
        • Pearson A.D.
        • London W.B.
        • Monclair T.
        • Ambros P.F.
        • Brodeur G.M.
        • et al.
        The international neuroblastoma risk group (INRG) classification system: an INRG task force report.
        J Clin Oncol. 2009; 27: 289-297
        • Kiely E.
        A technique for excision of abdominal and pelvic neuroblastomas.
        Ann R Coll Surg Engl. 2007; 89: 342-348
        • Grosfeld J.L.
        • Baehner R.L.
        Neuroblastoma: an analysis of 160 cases.
        World J Surg. 1980; 4: 29-38
        • Rees H.
        • Markley M.A.
        • Kiely E.M.
        • Pierro A.
        • Pritchard J.
        Diarrhea after resection of advanced abdominal neuroblastoma: a common management problem.
        Surgery. 1998; 123: 568-572
        • La Quaglia M.P.
        • Kushner B.H.
        • Su W.
        • Heller G.
        • Kramer K.
        • Abramson S.
        • et al.
        The impact of gross total resection on local control and survival in high-risk neuroblastoma.
        J Pediatr Surg. 2004; 39: 412-417
        • Kimura N.
        • Yamamoto H.
        • Okamoto H.
        • Wakasa H.
        • Nagura H.
        Multiple-hormone gene expression in ganglioneuroblastoma with watery diarrhea, hypokalemia, and achlorhydria syndrome.
        Cancer. 1993; 71: 2841-2846
      1. Bourdeaut F, de Carli E, Timsit S, Coze C, Chastagner P, Sarnacki S, Delattre O, Peuchmaur M, Rubie H, Michon J, Neuroblastoma Committee of the Societe Francaise des Cancers et Leucemies de l'Enfant et de lA (2009) VIP hypersecretion as primary or secondary syndrome in neuroblastoma: a retrospective study by the Societe Francaise des Cancers de l'Enfant (SFCE). Pediatr Blood Cancer 52:585-590. doi:10.1002/pbc.21912.

        • Han W.
        • Wang H.M.
        Refractory diarrhea: a paraneoplastic syndrome of neuroblastoma.
        World J Gastroenterol. 2015; 21: 7929-7932
        • Kiely E.M.
        Radical surgery for abdominal neuroblastoma.
        Semin Surg Oncol. 1993; 9: 489-492
        • Wang H.
        Diarrheal neuroblastoma: diagnosis and treatment.
        Pediatr Blood Cancer. 2014; 61: S247
        • Kiely E.M.
        The surgical challenge of neuroblastoma.
        J Pediatr Surg. 1994; 29: 128-133
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • Group P.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Bjellerup P.
        • Theodorsson E.
        • Kogner P.
        Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
        Eur J Cancer. 1995; 31A: 481-485
        • Murphy M.S.
        • Sibal A.
        • Mann J.R.
        Persistent diarrhoea and occult vipomas in children.
        Br Med J. 2000; 320: 1524-1526
        • Scheibel E.
        • Rechnitzer C.
        • Fahrenkrug J.
        • Hertz H.
        Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
        Acta Paediatr Scand. 1982; 71: 721-725
        • Tang K.T.
        • Lee H.C.
        • Liang D.C.
        • Chen S.H.
        • Liu H.C.
        • Sheu J.C.
        Neural-crest tumor presenting with chronic diarrhea: a report of three cases.
        J Formos Med Assoc. 2002; 101: 864-867
        • Czkwianianc E.
        • Zalewska-Szewczyk B.
        • Kobos J.
        • Socha-Banasiak A.
        • Janczar S.
        • Prymus-Kasinska S.
        • et al.
        Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports.
        Contemp Oncol. 2018; 22: 42-46
        • al-Mulhim I.
        Neuroblastoma in children: a 10-year experience in Saudi Arabia.
        J Trop Pediatr. 1998; 44: 77-80
        • Fraga J.C.
        • Aydogdu B.
        • Aufieri R.
        • Silva G.V.
        • Schopf L.
        • Takamatu E.
        • et al.
        Surgical treatment for pediatric mediastinal neurogenic tumors.
        Ann Thorac Surg. 2010; 90: 413-418
        • Zhang Y.T.
        • Feng L.H.
        • Zhang Z.
        • Zhong X.D.
        • Chang J.
        Different kinds of paraneoplastic syndromes in childhood neuroblastoma.
        Iran J Pediatr. 2015; 25: e266
        • Tian W.
        • Fei Y.
        • Liu Z.L.
        • Yao J.
        Standard resection procedure can increase the complete resection rate in pediatric patients with locally advanced abdominal neuroblastoma.
        Transl Cancer Res. 2016; 5: 607-612